Category Press Releases

Sail Biomedicines

Sail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors

Sail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors Sail Biomedicines, Inc., a pioneering biotechnology company at the forefront of programmable RNA-based medicines and a Flagship Pioneering-founded enterprise, today announced the appointment of Laura Sepp-Lorenzino, Ph.D., to its…

Read MoreSail Biomedicines Welcomes Dr. Laura Sepp-Lorenzino to Its Board of Directors
Biosciences

Perth Biosciences Collaborates with Japan’s Scrum Corporation for Distribution

Perth Biosciences Collaborates with Japan’s Scrum Corporation for Distribution Perth Biosciences, a pioneering leader in the accessibility and scalability of single-cell sequencing, has officially announced a strategic agreement with Tokyo-based Scrum Inc., a premier distributor of life sciences and biotechnology…

Read MorePerth Biosciences Collaborates with Japan’s Scrum Corporation for Distribution
BioMedicines

Endeavor BioMedicines Welcomes ILD Expert Dr. Lisa Lancaster as Chief Medical Officer

Endeavor BioMedicines Welcomes ILD Expert Dr. Lisa Lancaster as Chief Medical Officer Endeavor BioMedicines, a clinical-stage biotechnology company dedicated to developing groundbreaking treatments for life-threatening diseases, has announced the appointment of Lisa Lancaster, M.D., as its new Chief Medical Officer.…

Read MoreEndeavor BioMedicines Welcomes ILD Expert Dr. Lisa Lancaster as Chief Medical Officer
Thermo

Thermo Fisher Unveils Krios 5 Cryo-TEM for Enhanced Automation & Performance

Thermo Fisher Unveils Krios 5 Cryo-TEM for Enhanced Automation & Performance Thermo Fisher Scientific, a global leader in scientific innovation, has introduced the Thermo Scientific™ Krios™ 5 Cryo-TEM, a cutting-edge, atomic-resolution platform designed to revolutionize molecular imaging. By integrating enhanced…

Read MoreThermo Fisher Unveils Krios 5 Cryo-TEM for Enhanced Automation & Performance
Cancer Vaccine

Personalized Cancer Vaccine Market & Clinical Trials Outlook 2025 – 18+ Vaccines in Development

Personalized Cancer Vaccine Market & Clinical Trials Outlook 2025 – 18+ Vaccines in Development The “Personalized Cancer Vaccine Market Opportunity & Clinical Trials Outlook 2025″ report, now available from ResearchAndMarkets.com, highlights the growing significance of personalized cancer vaccines in the…

Read MorePersonalized Cancer Vaccine Market & Clinical Trials Outlook 2025 – 18+ Vaccines in Development